PTGX Key Financial Ratios - Protagonist Therapeutics, Inc

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	21.71	—	9.36%	9.85%
2026-03-31	17.76	—	-16.45%	-17.50%
2025-12-31	12.71	—	-19.48%	-21.17%
2025-09-30	13.05	—	6.54%	7.11%
2025-06-30	16.97	—	7.25%	7.79%
2025-03-31	17.26	—	7.57%	8.16%
2024-12-31	12.48	—	36.95%	40.75%
2024-09-30	10.7	—	28.29%	32.12%
2024-06-30	13.73	—	27.65%	31.40%
2024-03-31	15.72	—	25.76%	28.93%
2023-12-31	16.71	—	-22.06%	-23.45%
2023-09-30	11.66	—	-42.57%	-46.49%
2023-06-30	12.01	—	-42.94%	-46.80%
2023-03-31	10.15	—	-58.45%	-64.85%
2022-12-31	7.8	—	-51.38%	-59.09%
2022-09-30	7.53	—	-46.11%	-53.41%
2022-06-30	7.59	—	-42.73%	-49.51%
2022-03-31	7.86	—	-35.17%	-40.59%
2021-12-31	7.74	—	-36.11%	-41.85%
2021-09-30	8.37	—	-28.81%	-32.62%
2021-06-30	8.65	—	-20.16%	-22.80%
2021-03-31	8.27	—	-23.51%	-27.02%
2020-12-31	7.84	—	-20.39%	-23.66%
2020-09-30	5.29	—	-29.80%	-38.19%
2020-06-30	6.15	—	-32.63%	-43.83%
2020-03-31	3.46	—	-61.65%	-132.71%
2019-12-31	4.1	—	-49.82%	-96.53%
2019-09-30	4.68	—	-47.57%	-77.13%
2019-06-30	4.12	—	-44.48%	-78.13%
2019-03-31	5.02	—	-34.30%	-44.99%
2018-12-31	5.26	—	-27.91%	-34.59%
2018-09-30	6.12	—	-18.88%	-22.68%
2018-06-30	4.69	—	-17.60%	-22.48%
2018-03-31	4.19	—	-20.45%	-26.62%
2017-12-31	3.55	—	-22.57%	-30.64%
2017-09-30	1.87	—	-40.89%	-78.07%
2017-06-30	7.38	—	-67.27%	-77.69%
2017-03-31	8.68	—	-47.82%	-52.78%
2016-12-31	12.94	—	-39.55%	-42.46%
2016-09-30	19.11	—	-30.55%	-32.23%
2016-06-30	5.45	—	-113.34%	60.14%
2015-12-31	4.54	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	12.71	—	-19.48%	-21.17%
2024-12-31	12.48	—	36.95%	40.75%
2023-12-31	16.71	—	-22.06%	-23.45%
2022-12-31	7.8	—	-51.38%	-59.09%
2021-12-31	7.74	—	-36.11%	-41.85%
2020-12-31	7.84	—	-20.39%	-23.66%
2019-12-31	4.1	—	-49.82%	-96.53%
2018-12-31	5.26	—	-27.91%	-34.59%
2017-12-31	3.55	—	-22.57%	-30.64%
2016-12-31	12.94	—	-39.55%	-42.46%
2015-12-31	—	—	-100.09%	54.23%
2014-12-31	—	—	—	87.73%